RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 119 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $19,000 | -44.1% | 3,535 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $34,000 | -46.0% | 3,535 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $63,000 | -26.7% | 3,535 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $86,000 | +16.2% | 3,535 | +25.8% | 0.00% | 0.0% |
| Q1 2021 | $74,000 | +252.4% | 2,811 | 0.0% | 0.00% | +200.0% |
| Q4 2020 | $21,000 | +50.0% | 2,811 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $14,000 | -17.6% | 2,811 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $17,000 | +30.8% | 2,811 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $13,000 | -51.9% | 2,811 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $27,000 | +22.7% | 2,811 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $22,000 | -50.0% | 2,811 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $44,000 | -13.7% | 2,811 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $51,000 | +218.8% | 2,811 | +180.3% | 0.00% | +100.0% |
| Q4 2018 | $16,000 | -33.3% | 1,003 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $24,000 | – | 1,003 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 38,506,526 | $6,546,109 | 0.21% |
| HARBOURVEST PARTNERS LLC | 986,878 | $172,704 | 0.06% |
| Artal Group S.A. | 2,042,666 | $357 | 0.02% |
| Virtu Financial LLC | 68,825 | $12 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 1,277,196 | $222 | 0.00% |
| STATE OF MICHIGAN RETIREMENT SYSTEM | 640,000 | $110,144 | 0.00% |
| Baillie Gifford | 4,869,126 | $837,977 | 0.00% |
| Citadel Advisors | 600 | $103 | 0.00% |
| Tower Research Capital LLC (TRC) | 25 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 2,196 | $0 | 0.00% |